EBSCO Information Services / Merative
by EBSCO Information Services and Merative
· Based in United States →
— Advanced Clinical Decision Support. Your drug and disease database for current clinical answers.
Individual subscriptions: student version $149/year, practicing clinicians start at different price points. dynamedex $599/year, dynamedex with dyna ai $675/year (usa only for individual subscribers). institutional pricing available upon request.
Overview
DynaMedex, a medical AI tool by EBSCO Information Services and Merative, is an evidence-based clinical decision support resource. It integrates comprehensive disease content from DynaMed with drug information from Micromedex.
This tool is designed for a broad range of healthcare professionals, including physicians, specialists, advanced practice providers, pharmacists, and clinical learners, across various care settings.
DynaMedex aims to fit into clinical workflows by providing point-of-care access to information, often with EHR integration and mobile app accessibility. It offers daily updates based on literature surveillance and allows for personalized experiences.
Notable capabilities include:
- Dyna AI: An AI search tool that synthesizes DynaMedex content to answer clinical queries, with transparency into source references.
- Integrated Drug Information: Provides comprehensive adult and pediatric drug information, including dosing guidance, precautions, contraindications, adverse effects, and drug interaction/IV compatibility checkers.
- Disease Content: Offers peer-reviewed clinical content across over 30 specialties, including overviews, recommendations, and differential diagnosis resources.
- Workflow Support: Features like single sign-on, CME/MOC credit tracking, and one-click access to primary literature are intended to streamline workflow.
- Multilingual Search: Supports search capabilities in 15 different languages.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Specialty-specific content
- Clinical alerts
- Comprehensive drug resources
- Chemotherapy regimens
- Patient information and education
- Medical calculators
- Evidence-Based Medicine (EBM) summaries
Use Cases
- Rapid clinical reference at the point of care
- Drug interaction and dosage verification
- Development of chemotherapy treatment plans
- Patient education and shared decision-making
- Staying updated with the latest medical evidence
What Physicians Need to Know
Evidence Base
DynaMedex is firmly grounded in evidence-based medicine, systematically identifying and rigorously appraising medical literature. Its content development follows a rigorous framework encompassing Evidence-Based Methodology, Evidence-Based Practice, Editorial Process, and Guideline Surveillance. It continuously scans over 3,300 medical journals and more than 250 U.S. and international guideline organizations, critically appraising and grading evidence for quality, clinical significance, and applicability. Recommendations are synthesized from current evidence, and content is authored by actively practicing clinicians. Evidence reports and recommendations are labeled with levels of evidence (e.g., Level 1 for likely reliable evidence) and grades (e.g., Grade A for consistent high-quality evidence).
Clinical Validation Studies
A study published in the Journal of the Medical Library Association (JMLA) found that DynaMedex provided answers for 98% of 265 real-world clinical questions, with 97% of those answers rated as relevant to patient care. Another usability study (DynaMed and Micromedex with Watson, now DynaMedex) involving 43 clinicians reported an average ease of finding an answer of 5.68 out of 7. Additionally, a randomized crossover trial demonstrated DynaMed's noninferiority to UpToDate in terms of accuracy, time to answer, ease of use, quality of information, and ability to assess evidence among medical trainees.
Alert Fatigue Management
DynaMedex addresses alert fatigue through personalized alerts, allowing users to follow specific topics or specialties for relevant and potentially practice-changing updates. The system highlights answers to common clinical decision points and updates content daily, up to six times per day, to ensure currency and focus on critical information.
Drug Interaction Checking
The tool includes a comprehensive drug interaction checker from Micromedex, which allows for checking drug-drug and drug-allergy interactions. It provides clear indications of interaction severity (e.g., red for contraindication, orange for significant interaction, yellow for weak interaction). An IV compatibility checker is also integrated. Dyna AI is being expanded to integrate medication dosing and safety information, including pediatric and adult dosing guidance, precautions, contraindications, adverse effects, and black box warnings, directly into the workflow.
Differential Diagnosis Support
DynaMedex offers robust differential diagnosis resources, with comprehensive topics spanning diseases, conditions, and abnormal findings. DynaMed, a core component, provides peer-reviewed clinical content specifically for differential diagnosis.
Guideline Update Frequency
Content is continually updated in real-time to reflect the evolving clinical evidence. DynaMedex monitors over 250 U.S. and international guideline organizations using a proprietary surveillance system developed with McMaster University. Guidelines are evaluated and summarized by practicing physicians and methodologists, with content updated daily, up to six times per day. Recent guideline summaries, such as NCCN recommendations, are highlighted.
Clinical Workflow Integration
DynaMedex is designed for seamless integration into the clinical workflow, delivering fast, accurate answers at the point of care. It offers EHR integration with major systems like Epic, Cerner, Athena, GE, McKesson, MEDITECH, and Siemens, often via Infobuttons. Single sign-on access and a mobile app provide anytime, anywhere access. Dyna AI further enhances integration by providing relevant, expert-curated, and critically appraised clinical information directly within the workflow.
Decision Audit Trail
While other EBSCO products and general MFT servers mention audit logging, there is no explicit mention of a 'Decision Audit Trail' feature specifically for DynaMedex that tracks individual physician decisions or overrides within the tool itself in the provided search results.
Physician Tip
To maximize the benefits of DynaMedex, physicians should leverage personalized alerts to stay current with practice-changing updates relevant to their specialties. Utilize the integrated drug interaction and IV compatibility checkers for enhanced medication safety. Explore the differential diagnosis support to broaden diagnostic considerations and ensure comprehensive patient evaluation. Take advantage of seamless EHR integration and the mobile app for quick, evidence-based answers directly at the point of care. Additionally, remember that using DynaMedex for daily clinical practice can help you earn valuable CME/MOC credits. If available, utilize Dyna AI for even faster, expert-curated answers to complex clinical and medication-related queries.
DynaMedex is built for extensive integration, combining the clinical expertise of DynaMed with the comprehensive drug information of Micromedex into a unified platform. It offers robust EHR integration capabilities with leading systems such as Epic, Cerner, Athena, GE, McKesson, MEDITECH, and Siemens, often facilitated through Infobuttons. Dyna AI, an add-on, seamlessly integrates with DynaMedex to provide AI-generated summaries and enhanced search, particularly for drug and dosing information. The platform can also be integrated with EBSCO Discovery Service.
Details
| Category | Clinical Decision Support & Reference, Oncology AI, Pharmacology & Dosing AI |
| Pricing |
Individual subscriptions: student version $149/year, practicing clinicians start at different price points. dynamedex $599/year, dynamedex with dyna ai $675/year (usa only for individual subscribers). institutional pricing available upon request.
|
| Free Trial | Unknown |
| Deployment | Cloud, Web-based, Mobile App, EHR Integration (via HL7 Infobutton and toolbar links). |
| Mobile App | Yes, free mobile apps are available for iOS and Android devices, offering offline access. |
| API Available | Unknown |
| Languages | English (content), multiple languages (search functionality). |
| Training | Unknown |
| Target Size | Individual clinicians, Hospitals, Healthcare systems, Academic institutions, Government agencies. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated DynaMedex provides summaries of recently approved drugs, biological products, and medical devices from the FDA and EMA, but it is not explicitly stated that the DynaMedex software itself has FDA clearance. |
| GDPR | Unknown AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Multiple Specialties |
Social Proof
| Customers | Merative serves over 4,000 healthcare providers. |
| Notable | Nine out of the ten top U.S. hospitals (for Merative)Brigham and Women's HospitalMassachusetts General HospitalAmerican College of Physicians (ACP). |
Support & Reliability
| Training Provided | Unknown |
What the Web Says
DynaMedex, a product of EBSCO Information Services and Merative (formerly IBM Watson Health), is a clinical decision support tool that combines DynaMed's disease content with Micromedex's drug information. It aims to provide evidence-based answers quickly at the point of care, and in 2024, it launched Dyna AI for conversational AI search. While praised for its evidence-based methodology and comprehensive drug information, it often faces comparisons with UpToDate, with many physicians expressing a preference for the latter's narrative quality and depth.
Overall: MixedStrengths
- Combines comprehensive disease and drug information (DynaMed and Micromedex).
- Content is evidence-based, with rigorous methodology and clear grading of evidence.
- Provides concise summaries for rapid decision-making at the point of care.
- Offers CME/MOC credit tracking.
- Includes Dyna AI for conversational search, providing quick, sourced answers.
- Generally considered less expensive than UpToDate for institutions.
Limitations
- Physicians often prefer UpToDate for its narrative quality and depth of expert-authored reviews.
- Lower brand recognition among physicians compared to UpToDate.
- Some users report issues with integration into Electronic Medical Records (EMR) and mobile usability.
- The user interface for Merative (Micromedex) has been described as outdated by some.
- Fewer clinical topics covered compared to UpToDate (3,400 vs 12,000+).
- Merative (the IBM Watson Health acquisition) has faced internal challenges, including frequent layoffs and high turnover, leading to low employee morale.
Based on reviews from: Reddit, KLAS Research, EBSCO, EvidenceMD, Clinical AI Report, American College of Physicians, SourceForge, Apple App Store, Indeed.com, G2
Last updated: 2026-08-16
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate EBSCO Information Services / Merative
Press & Coverage
EBSCO Information Services Newsroom
DynaMedexu00ae Recognized as 2026 Best in KLAS for Clinical Decision Support
DynaMedex, an integrated clinical decision support solution from EBSCO Information Services and Micromedex by Merative, was recognized as the top-performing solution for clinical decision support: point-of-care disease reference in the KLAS 2026 Software and Services Report. This marks the sixth time EBSCO Information Services has received this honor.
2026-02
EBSCO Clinical Decisions
Dyna AI to integrate medication dosing and safety data into DynaMedex workflow
EBSCO Clinical Decisions and Micromedex announced an expansion of Dyna AI for DynaMedex that will integrate medication dosing and safety information directly into the clinical decision support platform, aiming for early 2026 availability. This enhancement will embed Micromedex medication intelligence into Dyna AIu2013generated responses, providing clinicians with immediate access to structured summaries.
2025-12
University of Nebraska Medical Center Newsroom
Navigating DynaMedex changes | Newsroom | University of Nebraska Medical Center
Nebraska Medicine and UNMC announced that DynaMedex will replace UpToDate as their primary clinical decision support tool starting July 1, 2025. DynaMedex will be accessible through various platforms, and resources are available to help familiarize providers with the change.
2025-06
UNMC Newsroom
DynaMedex to replace UpToDate on July 1 | Newsroom - UNMC
On July 1, 2025, Nebraska Medicine and UNMC will transition to DynaMedex as their new clinical decision support tool, replacing UpToDate. A comprehensive six-week trial and multidisciplinary committee evaluation led to this decision.
2025-06
Countway Library
New AI Search Feature In DynaMedex - Countway Library
Countway Library announced a new DynaMedex feature, Dyna AI, available to Harvard users, which leverages AI to retrieve and summarize peer-reviewed, evidence-based content within DynaMedex. Users must log into a free EBSCO user account to utilize Dyna AI.
2025-02
Ruth Lilly Medical Library News Archive - IU Blogs
Announcing DynaMedex! u2013 Ruth Lilly Medical Library News Archive - IU Blogs
Ruth Lilly Medical Library announced a new subscription to DynaMedex, which combines evidence-based content for clinical decision-making with drug information from Micromedex. DynaMedex will replace UpToDate after June 30th.
2024-06
EBSCO Health Notes Blog
DynaMedex u2013 Keeping Pace with the Evolution of Clinical Decision Support
This article discusses the evolution of DynaMedex, highlighting its growth from DynaMed, founded in 1995, to an expanded clinical decision support tool that addresses the increasing complexities of healthcare. DynaMedex now offers over 20,000 evidence-based clinical recommendations and daily updates.
2023-04
EBSCO Information Services Newsroom
DynaMedu00ae and Micromedexu00ae with Watsonu2122 is now DynaMedexu2122 - News | EBSCO
EBSCO Information Services and Merative announced that their integrated clinical decision support solution, formerly DynaMed and Micromedex with Watson, has been rebranded as DynaMedex. This new name signifies the continued enhancement of clinical decision support for healthcare providers.
2022-10
Videos
Product demos, reviews, and walkthroughs for EBSCO Information Services / Merative.
Webinar: Dynamed Micromedex with Watson, strumento di supporto decisionale per scelte terapeutiche
EBSCO Italia
Frequently Asked Questions
EBSCO's DynaMed and Merative's Micromedex, often combined as DynaMedex, are designed for seamless integration into Electronic Health Record (EHR) systems, offering features like referential links, contextual search, and HL7 Infobutton compliance. They also provide mobile apps for on-the-go access, allowing physicians to quickly find evidence-based answers at the point of care.
Yes, EBSCO's DynaMed Decisions is explicitly noted as HIPAA-compliant, and Merative's Micromedex is a trusted reference used by healthcare providers, payers, and insurers to ensure compliance with drug pricing and regulatory requirements. Both companies emphasize the use of impartial, curated clinical evidence to inform safe decision-making.
Key alternatives include UpToDate, ClinicalKey AI, BMJ Best Practice, and Epocrates. While many offer similar evidence-based content and drug information, differences lie in content presentation (e.g., DynaMed's bulleted format vs. UpToDate's narrative), AI integration maturity, and pricing transparency.
Pricing typically varies based on subscription type, user volume, and institutional agreements. For individual physicians, DynaMed offers subscriptions, for example, $399 per year without Dyna AI and $475 with it, often cited as more transparent and potentially lower cost than some competitors. Micromedex pricing is generally part of larger institutional contracts.
Common limitations include the potential for 'alert fatigue' from too many notifications, challenges with seamless integration into all proprietary EHR systems requiring significant IT work, and the necessity for clinicians to validate AI-generated outputs. The effectiveness also depends on the quality and completeness of ingested data.
Both EBSCO (with Dyna AI for DynaMed/DynaMedex) and Merative (with AI-powered search in Micromedex) utilize AI to deliver faster, more precise, and actionable evidence-based answers. AI helps streamline complex searches, minimize clicks, and quickly provide drug and disease information, with results citing trusted sources for validation.
Both DynaMed and Micromedex are known for their rigorous, evidence-based methodologies and frequent updates. Content is continuously reviewed and updated daily by clinical experts to reflect the latest medical literature, guidelines, and market changes, ensuring clinicians have access to the most current information.
Compare EBSCO Information Services / Merative
VS
BriefCase vs EBSCO Information Services / Merative
BriefCase focuses on AI-powered communication and collaboration for critical medical imaging findings, streamlining workflow for radiologists and care teams. DynaMedex with Dyna AI, conversely, is a comprehensive clinical…
VS
iatroX vs EBSCO Information Services / Merative
iatroX and DynaMedex with Dyna AI are both AI-powered clinical reference tools, offering instant answers and evidence-based support. However, iatroX places a strong emphasis on medical education and…
VS
OpenEvidence vs EBSCO Information Services / Merative
OpenEvidence and DynaMedex with Dyna AI are direct competitors, both offering AI-powered clinical decision support grounded in medical evidence. OpenEvidence emphasizes natural language querying and documentation, while DynaMedex…
VS
Heidi Health vs EBSCO Information Services / Merative
Heidi Health is primarily an AI medical scribe and care partner platform, focusing on automating clinical documentation, patient communication, and offering some clinical evidence support. In contrast, DynaMedex…
Suggest an Edit →
| Last Verified: 2026-07-03 | First Added: 2026-05-17